AI/ML Driven Drug DiscoverySoft Materials and Product DevelopmentEx vivo & In vitro ModelsEx vivo and In Vitro ModelsResolution Pharmacology (e.g., worm, fly, rodent models)Preventing diabetes cataracts and trating post-surgical ocular inflammationOral insulin for T2DA highly potent lymphatic system-targeting nanoparticle cyclosporine for treating lupusUrolithin A nonparticle therapy for acute kidney injuryNanoparticles that bind to TfR independent of transferrin
This website uses cookies to collect information to improve your browsing experience. Please review our Privacy Statement for more information.